InvestorsHub Logo
Followers 230
Posts 21508
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Thursday, 07/19/2018 9:39:53 AM

Thursday, July 19, 2018 9:39:53 AM

Post# of 2850
BIOLINERX Ltd/S ADR (NASDAQ: BLRX) is set to release Phase 3 results from the GENESIS clinical trial, which evaluates its BL-8040 for the mobilization of hematopoietic stem cells used for autologous transplantation in multiple myeloma patients.

See if that can help the chart.

https://finance.yahoo.com/news/week-ahead-biotech-conferences-pdufa-231635760.html

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News